episodic migraine

News

FDA clears first migraine DTx from Click Therapeutics

Click Therapeutics' digital therapeutic (DTx) for migraine prevention has been cleared by the FDA, becoming the first treatment of its type in the US.

News

NICE backs Lilly’s Emgality for migraine, adding pressure on...

UK cost-effectiveness agency NICE has said that Eli Lilly’s Emgality can be made available through the NHS for migraine prevention, the second drug in the CGRP inhibitor class to achieve th

News

Breakthrough migraine prevention treatment approved in Europ...

Novartis’ Aimovig (erenumab) has been approved by the European Medicines Agency (EMA) making it first self-administered, monthly migraine prevention jab available for adult patients in Euro

News

Migraine prevention drug Aimovig poised for EU approval

The first antibody treatment to prevent migraine (Aimovig), produced by Novartis, is on the cusp of approval.

FDA clears first migraine DTx from Click Therapeutics

NICE backs Lilly’s Emgality for migraine, adding pressure on...

Breakthrough migraine prevention treatment approved in Europ...

Migraine prevention drug Aimovig poised for EU approval

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

episodic migraine

Editor's Picks